Johnson & Johnson
corporate_fare Company Profile
Johnson & Johnson (NYSE:JNJ) is a publicly traded company in the Life Sciences sector. Wiseek monitors JNJ SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- EU Regulator Backs J&J's Oral Psoriasis Drug, First of Its Kind
- J&J Q2 2026: Sales Beat and Raised Guidance, but STELARA Erosion and Talc Overhang Linger
- J&J's Blood Cancer Combo Cuts Death Risk by 89% in Late-Stage Trial
- FDA Authorizes J&J's OTTAVA Robotic Surgical System, Entering $7B Market
- J&J's DePuy Synthes Buys Expanding Innovations, Bolstering Spine Portfolio
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for JNJ, detected from its recent SEC filings.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →